Delivery Order SPE2DB20D3103-SPE2DB23FN3Q7
Award Date
5/11/23
Potential Completion Date
6/2/23
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a firm fixed price of $4,466.57 and a completion date of October 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $13,399.71 and an ultimate completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the prescription medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a firm-fixed price delivery order with a ceiling value of $4,466.57 and an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide the medication to support military treatment facilities and other government healthcare programs. This order is part...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corporation for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $13,399.71 and an ultimate completion date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of its ongoing efforts to provide...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,466.57, is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 12, 2024. This award does not have a set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ZEPOSIA 0.92 MG CAPSULE 30S, a medication, with a ceiling value of $4,620.93 and a completion date of January 22, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULES in quantities of 30s, with a firm fixed-price ceiling value of $26,799.42. The contract has an ultimate completion date of November 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award, valued at $13,399.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 25, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The order is for the pharmaceutical product ZEPOSIA 0.92 MG CAPSULE 30S, with a ceiling value of $13,399.71 and a completion date of August 2, 2024. The contract is a firm-fixed price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award, valued at $13,399.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a medication used for various medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of February 1, 2024. The contract was not set aside for any specific business size or...